QualityStocksNewsBreaks – CytoDyn Inc. (CYDY) Names Richard G. Pestell, M.D., Ph.D. as Board Vice Chairman, Expanding Leadership Role in Advancement of Company Initiatives
Biotechnology company CytoDyn (OTCQB: CYDY) today announced the election of its Chief Medical Officer and Director Richard G. Pestell, M.D., Ph.D., M.B.A., F.A.C.P., F.R.A.C.P. to the additional position of vice chairman of the board of directors. In this added role Pestell, an internationally renowned clinician and cancer researcher and defining force in CCR5 antagonist research, will advance and accelerate CYDY’s initiatives in seeking non-dilutive licensing opportunities in cancer and immunology. “We are honored to have Dr. Pestell serve as our Vice Chairman,” CytoDyn President and Chief Executive Officer Nader Pourhassan stated in the news release. “He is a world renowned…